2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
A

2020 ASCO Update on HRAS-Mutant HNSCC: Does Tipifarnib Show Treatment Potential?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Anterpreet Neki
By 2020 ASCO Virtual Direct™ Highlights FEATURING Anterpreet Neki
0 views
January 5, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

20:09
AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
Head&Neck
05:57
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HRAS-Mutant HNSCC: Does Tipifarnib Show Treatmen…

Feat. A. Neki
08:02
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced Oropharynx Cancer: Is Transoral Resecti…

Feat. A. Neki
07:53
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on R/M ACC Management: What Is the Efficacy & T…

Feat. A. Neki
09:04
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on SCCHN Management: Is Weekly CDDP + RT More Benef…

Feat. A. Neki